-
Something wrong with this record ?
Effects of different hemodialysis modalities combined with low-calcium dialysate on mineral metabolism and vascular calcification in maintenance hemodialysis patients with chronic kidney disease
J. Wang, Y. Luo, X. Ji, H. Xu, Z. Liang, M. Zhou
Language English Country Czech Republic
Document type Journal Article, Randomized Controlled Trial
Grant support
2022A029
President Foundation of Nanfang Hospital, Southern Medical University - China
NLK
Directory of Open Access Journals
from 2019
ROAD: Directory of Open Access Scholarly Resources
from 2002
PubMed
40033811
DOI
10.32725/jab.2024.027
Knihovny.cz E-resources
- MeSH
- C-Reactive Protein metabolism analysis MeSH
- Renal Insufficiency, Chronic * therapy blood complications metabolism MeSH
- Renal Dialysis * adverse effects MeSH
- Dialysis Solutions pharmacology MeSH
- Adult MeSH
- Phosphorus blood MeSH
- Interleukin-6 blood MeSH
- Middle Aged MeSH
- Humans MeSH
- Minerals metabolism blood MeSH
- Parathyroid Hormone blood MeSH
- Aged MeSH
- Tumor Necrosis Factor-alpha blood MeSH
- Calcium * blood metabolism MeSH
- Vascular Calcification * blood MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Randomized Controlled Trial MeSH
OBJECTIVE: This research investigated the effects of different hemodialysis modalities combined with low-calcium dialysate (LCD) on mineral metabolism and vascular calcification (VC) in maintenance hemodialysis (MHD) patients with chronic kidney disease (CKD). METHODS: General data were collected from 192 cases of MHD patients, who were divided into 4 groups according to the randomized numerical table. Each group was given LCD treatment, and conventional hemodialysis (HD), high-flux HD (HFHD), hemodiafiltration (HDF), and HD + hemoperfusion (HP) were performed, respectively. The patients were dialyzed 3 times per week for 4 h each time, and each group was treated for 6 months. Fasting venous blood was collected. Serum interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and high-sensitive C-reactive protein (hs-CRP) levels were measured by ELISA, calcium (Ca2+), phosphorus (P), Ca2+-P product, serum creatinine (SCr), blood urea nitrogen (BUN), β2 microglobulin (β2-MG), and intact parathyroid hormone (iPTH) were measured by chemiluminescence immunoassay, serum alkaline phosphatase (ALP) was determined by turbidimetric assay, and 25-hydroxyvitamin D (25(OH)D) was measured by autoradiographic immunoassay. To assess the extent of calcification in the iliac artery and abdominal aorta, a multilayer spiral CT device was employed for abdominal scans. RESULTS: Serum IL-6, hs-CRP, TNF-α, Ca2+, P, Ca2+-P product, SCr, BUN, β2-MG, iPTH, and ALP levels decreased, while 25(OH)D levels increased in the four groups after treatment. The most pronounced effect on the reduction of IL-6, hs-CRP, TNF-α, Ca2+, P, Ca2+-P product, SCr, BUN, β2-MG, iPTH, and ALP was in the HD + HP group, followed by the HDF and HFHD groups, and then by the HD group. The rate of VC in the HDF, HFHD, and HD + HP groups was lower than that in the HD group, and the rate in the HD + HP group was lower than that in the HDF and HFHD groups. CONCLUSION: The combination of HD + HP and LCD in treating CKD with MHD is effective, evidently rectifying disruptions in serum Ca2+ and P metabolism, enhancing kidney function, lessening the body's inflammatory response, and lessening VC.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25011851
- 003
- CZ-PrNML
- 005
- 20250521143007.0
- 007
- ta
- 008
- 250506s2024 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.32725/jab.2024.027 $2 doi
- 035 __
- $a (PubMed)40033811
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Wang, Jing $u Southern Medical University, Nanfang Hospital, Blood Purification Unit, Guangzhou 510515, Guangdong China
- 245 10
- $a Effects of different hemodialysis modalities combined with low-calcium dialysate on mineral metabolism and vascular calcification in maintenance hemodialysis patients with chronic kidney disease / $c J. Wang, Y. Luo, X. Ji, H. Xu, Z. Liang, M. Zhou
- 520 9_
- $a OBJECTIVE: This research investigated the effects of different hemodialysis modalities combined with low-calcium dialysate (LCD) on mineral metabolism and vascular calcification (VC) in maintenance hemodialysis (MHD) patients with chronic kidney disease (CKD). METHODS: General data were collected from 192 cases of MHD patients, who were divided into 4 groups according to the randomized numerical table. Each group was given LCD treatment, and conventional hemodialysis (HD), high-flux HD (HFHD), hemodiafiltration (HDF), and HD + hemoperfusion (HP) were performed, respectively. The patients were dialyzed 3 times per week for 4 h each time, and each group was treated for 6 months. Fasting venous blood was collected. Serum interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and high-sensitive C-reactive protein (hs-CRP) levels were measured by ELISA, calcium (Ca2+), phosphorus (P), Ca2+-P product, serum creatinine (SCr), blood urea nitrogen (BUN), β2 microglobulin (β2-MG), and intact parathyroid hormone (iPTH) were measured by chemiluminescence immunoassay, serum alkaline phosphatase (ALP) was determined by turbidimetric assay, and 25-hydroxyvitamin D (25(OH)D) was measured by autoradiographic immunoassay. To assess the extent of calcification in the iliac artery and abdominal aorta, a multilayer spiral CT device was employed for abdominal scans. RESULTS: Serum IL-6, hs-CRP, TNF-α, Ca2+, P, Ca2+-P product, SCr, BUN, β2-MG, iPTH, and ALP levels decreased, while 25(OH)D levels increased in the four groups after treatment. The most pronounced effect on the reduction of IL-6, hs-CRP, TNF-α, Ca2+, P, Ca2+-P product, SCr, BUN, β2-MG, iPTH, and ALP was in the HD + HP group, followed by the HDF and HFHD groups, and then by the HD group. The rate of VC in the HDF, HFHD, and HD + HP groups was lower than that in the HD group, and the rate in the HD + HP group was lower than that in the HDF and HFHD groups. CONCLUSION: The combination of HD + HP and LCD in treating CKD with MHD is effective, evidently rectifying disruptions in serum Ca2+ and P metabolism, enhancing kidney function, lessening the body's inflammatory response, and lessening VC.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a dialýza ledvin $x škodlivé účinky $7 D006435
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a vápník $x krev $x metabolismus $7 D002118
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a vaskulární kalcifikace $x krev $7 D061205
- 650 12
- $a chronická renální insuficience $x terapie $x krev $x komplikace $x metabolismus $7 D051436
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a minerály $x metabolismus $x krev $7 D008903
- 650 _2
- $a TNF-alfa $x krev $7 D014409
- 650 _2
- $a interleukin-6 $x krev $7 D015850
- 650 _2
- $a dialyzační roztoky $x farmakologie $7 D015314
- 650 _2
- $a fosfor $x krev $7 D010758
- 650 _2
- $a parathormon $x krev $7 D010281
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a C-reaktivní protein $x metabolismus $x analýza $7 D002097
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 700 1_
- $a Luo, Yimian $u Southern Medical University, Guangzhou 510515, Guangdong, China
- 700 1_
- $a Ji, Xingyu $u Southern Medical University, Guangzhou 510515, Guangdong, China
- 700 1_
- $a Xu, Hao $u Southern Medical University, Guangzhou 510515, Guangdong, China
- 700 1_
- $a Liang, Zhenhua $u Southern Medical University, Guangzhou 510515, Guangdong, China
- 700 1_
- $a Zhou, Minjie $u Southern Medical University, Nanfang Hospital, Department of Organ Transplantation, Guangzhou 510515, Guangdong, China
- 773 0_
- $w MED00012667 $t Journal of applied biomedicine $x 1214-0287 $g Roč. 22, č. 4 (2024), s. 228-233
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40033811 $y Pubmed
- 910 __
- $a ABA008 $b B 2301 $c 1249 $y p $z 0
- 990 __
- $a 20250506 $b ABA008
- 991 __
- $a 20250521143005 $b ABA008
- 999 __
- $a ok $b bmc $g 2324879 $s 1248941
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 22 $c 4 $d 228-233 $e 20241216 $i 1214-0287 $m Journal of applied biomedicine $n J Appl Biomed $x MED00012667
- GRA __
- $a 2022A029 $p President Foundation of Nanfang Hospital, Southern Medical University $2 China
- LZP __
- $b NLK124 $a Pubmed-20250506